Compounds > tryptophan

tryptophan and Apolipoprotein B-100, Familial Defective

tryptophan has been researched along with Apolipoprotein B-100, Familial Defective in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biesecker, LG; Mullikin, JC; Ng, D; Spaulding, E1
Camare, R; Dang, QQ; Douste-Blazy, P; Galy, D1
Cacan, SL; Davignon, J; Giroux, LM; Lambert, M; Levy, E; Minnich, A; Thibault, L1
Andreasen, PH; Andresen, BS; Bolund, L; Faergeman, O; Gregersen, N; Hansen, PS; Heath, F; Holst, H; Jensen, HK; Jensen, LG; Jensen, TG; Jørgensen, MM; Kristiansen, K; Kølvraa, S; Neve, S1
Choong, ML; Khaw, MC; Khoo, KL; Koay, ES; Sethi, SK1
Gutierrez, G; Jobs, J; Korte, A; Manns, MP; Schmidt, H; Schneider, A; Stuhrmann, M1

Other Studies

6 other study(ies) available for tryptophan and Apolipoprotein B-100, Familial Defective

ArticleYear
Identification of a novel LDLR mutation (c.261_262invGA, p.Trp87X): Importance of specifying DNA and protein mutations.
    Atherosclerosis, 2010, Volume: 211, Issue:2

    Topics: Aged; Atherosclerosis; DNA; Female; Gene Expression Regulation; Genetic Variation; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Pedigree; Phenotype; Receptors, LDL; Tryptophan

2010
Fluorescence quenching by iodide ions of low density lipoproteins from normolipidemic and hypercholesterolemic type IIa subjects. Effect of low density lipoprotein-cholesterol and low density lipoprotein non-apolipoprotein-B.
    Chemistry and physics of lipids, 1984, Volume: 36, Issue:2

    Topics: Cholesterol, LDL; Fluorescence; Humans; Hyperlipoproteinemia Type II; Iodine; Lipoproteins, LDL; Protein Conformation; Tryptophan

1984
Association of an exon 3 mutation (Trp66-->Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family.
    Biochemical and molecular medicine, 1997, Volume: 60, Issue:1

    Topics: Apolipoproteins B; Apolipoproteins E; Canada; Child; Cholesterol; Exons; Family; Female; France; Glycine; Humans; Hyperlipoproteinemia Type II; Ligands; Lipids; Lipoprotein Lipase; Lipoproteins; Male; Pedigree; Point Mutation; Polymorphism, Genetic; Receptors, LDL; Triglycerides; Tryptophan

1997
A common W556S mutation in the LDL receptor gene of Danish patients with familial hypercholesterolemia encodes a transport-defective protein.
    Atherosclerosis, 1997, Volume: 131, Issue:1

    Topics: Amino Acid Sequence; Animals; Base Sequence; Conserved Sequence; COS Cells; Denmark; Exons; Flow Cytometry; Fluorescent Antibody Technique; Humans; Hyperlipoproteinemia Type II; Microscopy, Confocal; Point Mutation; Receptors, LDL; Repetitive Sequences, Nucleic Acid; Serine; Transfection; Tryptophan

1997
Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500-->tryptophan mutation associated with a unique haplotype.
    Clinical chemistry, 1997, Volume: 43, Issue:6 Pt 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins B; Apolipoproteins E; Arginine; Child; Child, Preschool; Cholesterol; Cholesterol, LDL; Codon; Cohort Studies; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Ethnicity; Exons; Female; Genotype; Haplotypes; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Nucleic Acid Denaturation; Polymorphism, Genetic; Receptors, LDL; Tryptophan

1997
Homozygous familial hypercholesterolemia: A novel point mutation (W556R) in a Turkish patient.
    Human mutation, 2000, Volume: 16, Issue:4

    Topics: Adult; Amino Acid Substitution; Arginine; Child, Preschool; Female; Homozygote; Humans; Hyperlipoproteinemia Type II; Point Mutation; Tryptophan; Turkey

2000